Abstract
Globally, primary toxoplasmosis on gestation generates annually 190,100 new cases of congenital toxoplasmosis with a global burden of 1.20 million DALYs. Although Toxoplasma gondii infection is easily diagnosable and effectively treatable on the mother, out of prenatal screening setting, newborn diagnosis and early treatment might be problematic. In fact, the large majority of infected newborn display normal on clinical examination, with positive IgG of maternal origin and possibly negative IgA and IgM, with the consequence of late treatment on subclinical cases who are the ideal target of long-term pharmacological treatment. Moreover, toxoplasmosis is on the list of neglected disease of poverty. As consequence, the interest of manufacturers shows low, and standard of treatment continues to rely on a not curative and toxic medicine combination. Fortunately, research in progress on Toxoplasma gondii and host genetics and epigenetic machinery, including unusual histone variants and plantlike transcriptional and posttranscriptional motifs, could pave the way to potential new drugs and/or to channel the choice to treat or not to treat (and how long) subclinical onset forms. On the chapter, practical sustain on management at birth and on the long term of infant exposed to maternal Toxoplasma gondii infection or definitely congenitally infected (text, tables, and figure) is updated on the state of the art.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bahia-Oliveira LM, Jones JL, Azevedo-Silva J et al (2003) Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis 9(1):55–62
Belaz S, Gangneux JP, Dupretz P et al (2015) A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR. J Clin Microbiol 53:1294–1300
Blankenberg FG, Loh NN, Bracci P et al (2000) Sonography, CT, and MR imaging: a prospective comparison of neonates with suspected intracranial ischemia and hemorrhage. AJNR Am J Neuroradiol 21:213–218
Bodaghi B, Touitou V, Fardeau C et al (2012) Toxoplasmosis: new challenges for an old disease. Eye (Lond) 26(2):241–244
Boughattas S, Abdallah RB, Siala E et al (2011) An atypical strain associated with congenital toxoplasmosis in Tunisia. New Microbiol 34:413–416
Bowie WR, King AS, Werker DH et al (1997) Outbreak of toxoplasmosis associated with municipal drinking water: the BC Toxoplasma Investigation Team. Lancet 350:173–177
Boyer KM, Holfels E, Roizen N et al (2005) Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynaecol 192:564–571
Capobiango JD, Mitsuka-Breganò R, Cabral-Monica T et al (2015) Acute toxoplasmosis in a breastfed infant with possible transmission by water. Rev Inst Med Trop Sao Paulo 57(6):523–526
Carme B, Demar M, Ajzenberg D, Dardé ML (2009) Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis 15:656–658
Chapey E, Wallon M, L'Ollivier C et al (2015) Place of interferon-γ assay for diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J 34(12):1407–1409
de Souza NE, Land Curi AL, Cavalcanti de Albuquerque M et al (2012) Genetic polymorphism for IFNγ +874 T/A in patients with acute toxoplasmosis. Rev Soc Bras Med Trop 45:757–760
Delhaes L, Ajzenberg D, Sicot B et al (2010) Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review. Prenat Diagn 30:902–905
Dubey JP, Velmurugan GV, Rajendran C et al (2011) Genetic characterisation of Toxoplasma gondii in wildlife from North America revealed widespread and high prevalence of the fourth clonal type. Int J Parasitol 41:1139–1147
Dunn D, Wallon M, Peyron F et al (1999) Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829–1833
Dutra MS, Béla ST, Peixoto-Rangel AL et al (2013) Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis. JID 207:152–163
Elbez-Rubinstein A, Ajzenberg D, Dardé ML et al (2009) Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis 199(2):280–285
EMSCOT- European Multicentre Study on Congenital Toxoplasmosis (2007) Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 14:8–13
European Multicentre Study on Congenital Toxoplasmosis- EMSCOT (2008) Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics 121(5):e1215–e1222
Filisetti D, Odile Villard HI, Escande B et al (2015) Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis. J Clin Microbiol 53:1719–1721
Fox BA, Rommereim LM, Guevara RB et al (2016) The Toxoplasma gondii rhoptry kinome is essential for chronic infection. MBio 78(3):e00193–e00116. https://doi.org/10.1128/mBio.00193-16
Freeman K, Salt A, Prusa A et al (2005) Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children. BMC Pediatr 5:23
Gangneux F, Dardè ML (2012) Epidemiology and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25:264–296
Gilbert RE, Freeman K, Lago EG et al (2008) Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2(8):e277
Hintz SR, Slovis T, Bulas D et al (2007) Interobserver reliability and accuracy of cranial ultrasound scanning interpretation in premature infants. J Pediatr 150:592–596
Hutson SL, Wheeler KM, McLone D et al (2015) Patterns of hydrocephalus caused by congenital Toxoplasma gondii infection associate with parasite genetics. Clin Infect Dis 61(12):1831–1834
Jamieson SE, de Roubaix LA, Kuan Tan H et al (2008) COL2A1 and ABCA4 have epigenetically modified and associated with congenital toxoplasmosis. PLoS One 3(6):e2285. https://doi.org/10.1371/journal.pone.0002285
Jamieson SE, Peixoto-Rangel AL, Aubrey AC et al (2010) Evidence for associations between the purinergic receptor P2X7 (P2RX7) and toxoplasmosis. Genes Immun 11(5):374–383
Jones JL, Parise ME, Fiore AE (2014) Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg 90(5):794–799
Knoblauch H, Tennstedt C, Brueck W et al (2003) Two brothers with findings resembling congenital intrauterine infection-like syndrome (pseudo-TORCH syndrome). Am J Med Genet 120A:261–265
L’Ollivier C, Wallon M, Faucher B et al (2012) Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis. Clin Vaccine Immunol 19:1326–1328
Li XL, Wei HX, Zhang H et al (2014) A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PLOS One 9:e97775. https://doi.org/10.1371/journal.pone.0097775
Li X, Pomares C, Gonfrier G et al (2016) Multiplexed anti-toxoplasma IgG, IgM, and IgA assay on plasmonic gold chips: towards making mass screening possible with dye test precision. J Clin Microbiol 54:1726–1733
Liu L, Liu T, Yu L et al (2012) Rrop2(186-533): a novel peptide antigen for detection of IgM antibodies against Toxoplasma gondii. Foodborne Pathog Dis 9(1):7–12
Marangoni A, Capretti MG, De Angelis M et al (2014) Evaluation of a new protocol for retrospective diagnosis of congenital toxoplasmosis by use of Guthrie cards. J Clin Microbiol 52:2963–2970
McLeod R, Boyer K, Karrison T et al (2006) Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 42:1383–1394
McLeod R, Lykins J, Noble AG et al (2014) Management of congenital toxoplasmosis. Curr Pediatr Rep 2:166–194
Murat JB, Souvignet A, Fricker-Hidalgo H et al (2015) Assessment of the IgA immunosorbent agglutination assay for the diagnosis of congenital toxoplasmosis on a series of 145 toxoplasmic seroconversions. Clin Vaccine Immunol 22:456–458
Nguyen E, MacDonald WR, Trivedi T et al (2016) Neurons are the primary target cell for the brain- tropic intracellular parasite Toxoplasma gondii. PLoS Pathog 12(2):e1005447. https://doi.org/10.1371/journal. ppat.1005447
Noble AG, Latkany P, Kusmierczyk J et al (2010) Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago- based Congenital Toxoplasmosis Study. Sci Med (Porto Alegre) 20:20–26
Peyron F, Garweg JG, Wallon M et al (2011) Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis J 30:597–600
Phan L, Kasza K, Jalbrzikowski J et al (2008a) Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol 146(3):375–384
Phan L, Kasza K, Jalbrzikowski J et al (2008b) Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology 115(3):553–559
Pinon JM, Dumon H, Chemla C et al (2001) Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 39:2267–2271
Rajapakse S, Shivanthan MC, Samaranayake N et al (2013) Antibiotics for human toxoplasmosis: a systematic review of randomized trials. Pathog Glob Health 107:162–169
Rico-Torres CP, Vargas-Villavicencio JA, Correa D (2016) Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur J Clin Microbiol Infect Dis 35:1079–1088
Rilling V, Dietz K, Krczal D et al (2003) Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 22(3):174–180
Romand S, Chosson M, Franck J et al (2004) Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol 190(3):797–802
Saadatnia G, Golkar M (2012) Review on human toxoplasmosis. Scand J Infect Dis 44:805–814
Silveira C, Belfort R Jr, Muccioli C et al (2002) The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 134:41–46
Silveira C, Ferreira R, Muccioli C et al (2003) Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol 136(2):370–371
Stagni L, Romano MA, Romano A et al (2009) Prenatal screening for congenital toxoplasmosis in Campania: preliminary report on activities and results. Mem Inst Oswaldo Cruz 104(2):374–377
Stramba-Badiale M, Nador F, Porta N et al (1997) QT interval prolongation and risk of life-threatening arrhythmias during toxoplasmosis prophylaxis with spiramycin in neonates. Am Heart J 133(1):108–111
Systematic Review on Congenital Toxoplasmosis Study Group (SYROCOT) (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369:115–122
Torgerson PR, Mastroiacovo P (2013) The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 91(7):501–508
Torgerson PR, Devleesschauwer B, Praet N et al (2015) World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: a data synthesis. PLoS Med 12(12):e1001940. https://doi.org/10.1371/journal.pmed.1001940
Torres-Morales E, Taborda L, Cardona N et al (2014) Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis. Med Microbiol Immunol 203:315–322
Valentini P, Buonsenso D, Barone G et al (2015) Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy. J Perinatol 35(2):90–94
Villard O, Cimon B, L’Ollivier C et al (2016) Serological diagnosis of Toxoplasma gondii infection: Recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis 84:22–33
Wallon M, Peyron F, Cornu C et al (2013) Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis 56(9):1223–1231
Wallon M, Garweg JG, Abrahamowicz M et al (2014) Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence. Pediatrics 133:e601
Wallon M, Kieffer F, Huissoudd C, Peyron F (2015) Cesarean delivery or induction of labor does not prevent vertical transmission of toxoplasmosis in late pregnancy. Int J Gynecol Obstet 129:169–177
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Buffolano, W. (2018). Toxoplasmosis in the Fetus and Newborn. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Cham. https://doi.org/10.1007/978-3-319-29489-6_253
Download citation
DOI: https://doi.org/10.1007/978-3-319-29489-6_253
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29487-2
Online ISBN: 978-3-319-29489-6
eBook Packages: MedicineReference Module Medicine